rotenone has been researched along with piperine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Gao, G; Liu, J; Wang, H; Wang, X; Wu, X; Yang, H | 1 |
| Chen, M; Duan, C; Gao, G; Liu, J; Lu, L; Wang, X; Wang, Y; Wu, X; Yang, H | 1 |
| Das, M; Kundu, P; Sahoo, SK; Tripathy, K | 1 |
| Raj, K; Sharma, S; Singh, S | 1 |
5 other study(ies) available for rotenone and piperine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Protection effect of piperine and piperlonguminine from Piper longum L. alkaloids against rotenone-induced neuronal injury.
Topics: Alkaloids; Animals; Antiparkinson Agents; Apoptosis; Autophagy; Benzodioxoles; Brain; Cell Line; Dioxolanes; Drug Evaluation, Preclinical; Humans; Male; Mice; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Phytotherapy; Piper; Piperidines; Plant Extracts; Polyunsaturated Alkamides; Random Allocation; Rats, Wistar; Rotenone | 2016 |
Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson's disease model.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Antioxidants; Autophagy; Benzodioxoles; Cell Survival; Dopaminergic Neurons; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Parkinson Disease, Secondary; Piperidines; Polyunsaturated Alkamides; Protein Phosphatase 2; Rats; Rotenone; Substantia Nigra | 2016 |
Delivery of Dual Drug Loaded Lipid Based Nanoparticles across the Blood-Brain Barrier Impart Enhanced Neuroprotection in a Rotenone Induced Mouse Model of Parkinson's Disease.
Topics: Alkaloids; alpha-Synuclein; Animals; Antiparkinson Agents; Benzodioxoles; Blood-Brain Barrier; Capillary Permeability; Curcumin; Drug Delivery Systems; Drug Therapy, Combination; Liposomes; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Neuroprotective Agents; Parkinsonian Disorders; PC12 Cells; Piperidines; Polyunsaturated Alkamides; Protein Aggregation, Pathological; Random Allocation; Rats; Rotenone; Surface-Active Agents | 2016 |
Neuroprotective Effect of Quercetin in Combination with Piperine Against Rotenone- and Iron Supplement-Induced Parkinson's Disease in Experimental Rats.
Topics: Alkaloids; Benzodioxoles; Corpus Striatum; Dietary Supplements; Drug Synergism; Electron Transport Complex I; Electron Transport Complex IV; Glutathione; Indoles; Interleukin-1beta; Interleukin-6; Iron; Lipid Peroxidation; Neuroprotective Agents; Neurotransmitter Agents; Nitrites; Parkinson Disease, Secondary; Piperidines; Polyunsaturated Alkamides; Quercetin; Rotenone; Tumor Necrosis Factor-alpha | 2020 |